Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Triciribine |
Trade Name | |
Synonyms | VQD-002|API-2 |
Drug Descriptions |
Triciribine (API-2) is a purine analog that inhibits DNA synthesis, and blocks Akt phosphorylation, which may reduce proliferation and promote apoptosis in cancer cells (PMID: 21636709, PMID: 19422047). |
DrugClasses | Akt Inhibitor (Pan) 21 |
CAS Registry Number | 61966-08-3 |
NCIT ID | C1262 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Triciribine | Carboplatin Triciribine | 0 | 1 |
Cytarabine + Triciribine | Cytarabine Triciribine | 0 | 1 |
Doxorubicin + Triciribine | Doxorubicin Triciribine | 0 | 0 |
NVP-TNKS656 + Triciribine | NVP-TNKS656 Triciribine | 1 | 0 |
Paclitaxel + Triciribine | Paclitaxel Triciribine | 0 | 1 |
Trametinib + Triciribine | Trametinib Triciribine | 0 | 0 |
Triciribine | Triciribine | 0 | 0 |